Facebook
Twitter
LinkedIn
WhatsApp

NEWS three days ago – Metastatic Pancreatic Cancer to the liver

All treatments – have failed.

He received a combination of two drugs:  a biological drug by the name “MEKINIST”, which is FDA approved for Melanoma, and another FDA approved Malaria drug by the name “PLAQUENIL”. He had an enormous response!

And I ask, why wait??

To watch

 

To check if our service suits your case
We need to talk

Improve therapeutic outcomes, prolong life and quality of life, is our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Tags
ASCO 2025 (2) ASCO 2026 (3) Biological Drugs (106) Breakthrough Therapy Designation (1) Breast Oncology (1) Cancer Research (2) CAR T treatments (6) CDK4/6 Inhibitors (1) centralny układ nerwowy (1) Chemotherapy (72) Clinical Trial Enrollment (1) Clinical Trials (2) Daraxonrasib (1) Fulvestrant (1) Gedatolisib (1) Genetic Engineering Treatments (6) Genomic Testing (24) Hormone Receptor Positive Breast Cancer (1) Immunotherapy (76) innowacyjne terapie onkologiczne (3) Keytruda (24) KRAS (1) leczenie LMD (1) leki biologiczne (1) Medical Cannabis (3) Metastatic Pancreatic Cancer (1) nadzieja dla pacjentów (1) Novel Cancer Therapies (1) nowe leczenie raka (1) Oncology (2) OrigAMI-4 (1) Personalized Medicine (1) Precision Oncology (2) przerzuty do opon mózgowo-rdzeniowych (1) Recurrent Head and Neck Cancer (1) Revolution Medicines (1) Rybrevant (1) Rybrevant FASPRO (1) Stage 4 Cancer (150) Stage IV Breast Cancer (1) Tango Therapeutics (1) Targeted Drugs (57) Targeted Therapy (2) Trial-In Pharma (2) VIKTORIA-1 (1)

Recent articles

All articles